8.15am-6.30pm EDT | 5.15am-3.30pm PDT

8:15 am Online Registration & Virtual Coffee Networking

8:45 am Chair’s Opening Remarks

Discussing Central Features in Cell Therapy Supply Chains

9:00 am Outlining the Core Paradigms in Supply Chain Requirements for Cell Therapies and Innovations in Process Optimization

9:30 am Clinical Manufacturing and Banking of Virus Specific T Cells

  • Nan Zhang GMP Cellular Therapy Lead, Children’s National Health System

10:00 am Morning Refreshments & Virtual Speed Networking

Maintaining Product Quality in the Clinic

11:00 am Standardizing Cell Collection and Proposing ‘Best Practices’ in the Clinic

  • Jean Stanton Director Commercial Apheresis Operations, The Janssen Pharmaceutical Companies of Johnson & Johnson

11:20 am Maintaining Quality at Scale to Effectively Meet the Growing Demand for Cell Therapies

11:40 am Panel Discussion: Considering Best Practice, Requirements and Approaches to Center Oversight and Audit to Assure Quality of Care and Materials

  • Albert Ribickas Supervisor, Cell Therapy Facility, Moffitt Cancer Center
  • Alexandra Gomez Associate Director Patient Services Operations, bluebird bio
  • Jean Stanton Director Commercial Apheresis Operations, The Janssen Pharmaceutical Companies of Johnson & Johnson
  • Jennifer Rabin Specialist Master, Deloitte Consulting LLP
  • Kirstin Powel Global Head, External Quality Operations, Novartis Cell Therapy

12:30 pm Lunch & Workshop Session: Working with Sites and Proposing Standard Practices to Optimize Therapeutic Delivery and Patient Care

  • Alexandra Gomez Associate Director Patient Services Operations, bluebird bio

Transport and Logistics

2:00 pm Validating Transport and Equipment for Highly Robust Cell Therapy Supply Chains

  • Devin Blass Senior Director of Manufacturing and Supply Chain, Talaris Therapeutics

2:30 pm Panel Discussion: Comparing the Logistics Requirements and Restraints of Autologous vs. Allogeneic Therapies, and Avenues to Adapt Autologous Supply Chains to Allogeneic Products

3:15 pm Afternoon Virtual Networking

Proposing Industry Standards for Cell Immunotherapy Delivery

3:45 pm Standardizing Processes at the Front-End of the Supply Chain to Optimize Clinical Interfaces and Starting Material Quality

4:05 pm Mind the Gap: Clinical study to Commercial Success

4:15 pm End-to-End Integration at the Clinic for Seamless Cell Therapy Delivery

4:45 pm Developing Global Standards to Provide Quality Assurance to Reagents and Support Robust Supply Chain Design

5:15 pm Chair’s Closing Remarks

5:30 pm Virtual Happy Hour

Synopsis

The time of day we’ve all been waiting for! Grab a beverage of your choice from your home bar and use this final networking opportunity to follow up on connections made earlier in the day, ask that burning question to a speaker whose talk got you thinking and forge relations that could lead to your next collaboration.

6:30 pm End of Day 1